EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Seers Technology (458870) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Seers Technology KRW 5,504, price KRW 25,050, upside -78.0%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · KR

ST Thin data Sep 23, 2026

Seers Technology

458870 · KQ

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value 5,504 KRW · Strongly overvalued (−78%)
!Quality 60/100
!Expensive Growth (revenue 3y +247.0 %/yr)
✓Highly profitable · 39.7% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (9/10)
✓Wide moat 92/100
!Evidence only low, so the estimate is less certain
Watch Seers Technology for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

63,000 KRW 2,860 KRW Fair Value 5,504 KRW Jun 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

27‑month range 2,860 KRW – 63,000 KRW · fair‑value band 3,688 KRW – 7,566 KRW · the 25,050 KRW price screens above the 5,504 KRW fair value. Dashed = 300-day average. As of Sep 23, 2026.

Follow Seers Technology in your weekly email

Every Wednesday you see whether Seers Technology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea. It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material.

Show more

SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea. It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material. The company was formerly known as Seers Technology Co., LTD. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.

Stock analysis

Seers Technology (458870) currently trades at 25,050 KRW, while our model-based Fair Value estimate is 5,504 KRW, implying the stock looks roughly 355.2% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 19,640 KRW per share, and 0 of the 23 models we run sit above the 25,050 KRW price.

Bear case: the Asset-Based group reads lowest at 696.49 KRW, and 23 of the 23 models stay below the price. Evidence for this calculation is low.

Scenario range: 3,688 KRW (bear) to 7,566 KRW (bull), the price of 25,050 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Seers Technology reported revenue of 48.2B KRW in FY2025 versus 1.4B KRW in FY2021, a compound +142.8%/yr. Reported net income was 16.1B KRW in FY2025.

Key figures

Market cap 1.1T KRW (≈ $766M) · P/S ratio 14.3 · Net margin 33.4% · Return on equity 80.4% · Return on assets (EBIT) −22.8% · Operating margin 42.6% · Revenue (TTM) 76.6B KRW · Revenue growth (YoY) +700%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 60% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −78%, 458870 screens richer than that median.

Fair Value models

Bear 3,688 KRW Fair Value 5,504 KRW Bull 7,566 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 592.99 KRW 777.60 KRW 1,381 KRW 73
Growth DCF 575.65 KRW 883.69 KRW 1,401 KRW 72
EPV 3,681 KRW 4,279 KRW 4,810 KRW 71
All 23 models by family
DCF Models
FCF DCF 592.99 KRW 777.60 KRW 1,381 KRW 73
Owner Earnings 7,267 KRW 16,635 KRW 37,181 KRW 65
5Y Revenue Exit 2,570 KRW 4,835 KRW 9,624 KRW 63
5Y EBITDA Exit 4,129 KRW 7,988 KRW 15,590 KRW 66
5Y P/E Exit 5,759 KRW 14,252 KRW 26,127 KRW 62
10Y Revenue Exit 1,950 KRW 5,351 KRW 7,961 KRW 60
10Y EBITDA Exit 3,239 KRW 8,787 KRW 19,083 KRW 58
10Y P/E Exit 4,456 KRW 12,380 KRW 26,120 KRW 54
Earnings-Based
Graham-Dodd 2,875 KRW 20,047 KRW 28,133 KRW 59
Lynch FV 10,357 KRW 14,796 KRW 19,234 KRW 57
PEG = 1.0 10,357 KRW 14,796 KRW 19,234 KRW 53
EPV 3,681 KRW 4,279 KRW 4,810 KRW 71
Multiples
P/E Multiple 6,975 KRW 9,300 KRW 11,625 KRW 63
P/S Multiple 3,322 KRW 4,430 KRW 5,537 KRW 58
P/B Multiple 3,508 KRW 4,678 KRW 5,847 KRW 55
EV/EBIT 5,761 KRW 7,584 KRW 9,408 KRW 66
EV/EBITDA 5,157 KRW 6,779 KRW 8,401 KRW 67
EV/Revenue 2,949 KRW 4,089 KRW 5,228 KRW 54
Asset-Based
NCAV (Graham) 519.77 KRW 696.49 KRW 1,040 KRW 54
Growth DCF
Growth DCF 575.65 KRW 883.69 KRW 1,401 KRW 72
Economic Profit
Residual Income 3,664 KRW 5,482 KRW 78,533 KRW 53
ROIC Compounder 4,652 KRW 6,979 KRW 10,160 KRW 66
Growth Earnings
Growth-Adj P/E 13,748 KRW 19,640 KRW 25,532 KRW 63

Open the full fair value analysis →

Notify me when 458870 reaches fair value

Put 458870 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 60/100

Of which business quality 58 · Market factors (momentum, volatility) 33

Profitability 93
Margins and returns on capital today
Quality Growth 100
Are margins and returns improving?
Cashflow 12
Earnings quality: real cash, not paper profit
Fin. Strength 93
Balance sheet, leverage, solvency risk
Investment 31
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 39
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+494.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+247.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−316.6% (2021) → 33.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

458870 screens 355% overvalued. Compare with Abbott Laboratories, →

Compare Seers Technology with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 358 stocks

Beats the industry median on 8/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 60 · Above median
Fair Value upside −78% · Bottom 25%
Profitability
Return on equity (TTM) 80% · Top 25%
Return on assets 25% · Top 25%
Net margin (TTM) 40% · Top 25%
Operating margin (TTM) 43% · Top 25%
Growth and dividend
Revenue growth 700% · Top 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/S (TTM) 0.01× · Cheapest 25%
P/FCF 1.7× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 4
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)100 · sector 7
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)0 · sector 38

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $103.69 $74.79 −28%
Stryker Corporation SYK $275.09 $302.60 +10%
Medtronic plc MDT $90.77 $65.57 −28%
Boston Scientific Corporation BSX $44.92 $49.41 +10%
Edwards Lifesciences Corporation EW $88.78 $82.04 −8%
Siemens Healthineers AG SHL €37.43 €35.22 −6%
DexCom, Inc DXCM $89.53 $98.48 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Seers Technology · Fair Value
5,504 KRW −355%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Seers Technology Fair Value". https://www.fairvalue-calculator.com/stock/458870

Frequently asked questions

Is Seers Technology (458870) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 5,504 KRW versus a price of 25,050 KRW, about −78% upside (overvalued).
What is the fair value of 458870?
Our model-based fair value for Seers Technology is 5,504 KRW (as of Sep 23, 2026), built from audited fundamentals. The current price: 25,050 KRW.
What is the quality score of 458870?
Seers Technology has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Seers Technology (458870)?
Our model-based price target is the fair value of 5,504 KRW (as of Sep 23, 2026) from 23 valuation models. Cautious scenario 3,688 KRW, optimistic scenario 7,566 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Seers Technology stock forecast for 2026?
Our models put fair value at 5,504 KRW, about −78% upside versus a price of 25,050 KRW (overvalued). Cautious scenario 3,688 KRW, optimistic scenario 7,566 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Seers Technology (458870)?
Seers Technology reported trailing-twelve-month revenue of about 76.6B KRW (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Seers Technology (458870)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Seers Technology it is 5,504 KRW per share (as of Sep 23, 2026), against a price of 25,050 KRW. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Seers Technology stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 458870 trades above its calculated fair value: price 25,050 KRW, fair value 5,504 KRW, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 458870?
No. The price is what the market pays today (25,050 KRW); the fair value is what the company's own numbers justify (5,504 KRW). For Seers Technology the two are 19,546 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Seers Technology worth?
The market values Seers Technology at about 1.1T KRW (market capitalisation, as of Sep 23, 2026). Per share that is 25,050 KRW; our models calculate a fair value of 5,504 KRW per share.
What do the bullish and bearish scenarios say about 458870?
Our models span a range for Seers Technology: cautious scenario 3,688 KRW, base 5,504 KRW, optimistic 7,566 KRW per share (as of Sep 23, 2026, price 25,050 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Seers Technology (458870)?
Balance-sheet figures for Seers Technology (as of Sep 23, 2026): return on equity 80.4%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is 458870 from its 52-week high?
Seers Technology trades at 25,050 KRW, about 60% below its 52-week high of 63,000 KRW and 25% above the low of 19,967 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 5,504 KRW is for.
Which stocks are comparable to Seers Technology?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Seers Technology stock attractive at the current price?
The data as of Sep 23, 2026: price 25,050 KRW, calculated fair value 5,504 KRW (−78%), Quality Score 60/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 458870 calculated?
We run Seers Technology through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 5,504 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Seers Technology itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Seers Technology (458870)?
The closing price on Sep 23, 2026 was 25,050 KRW. Our model-based fair value is 5,504 KRW, about −78% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Seers Technology right now?
The price sits above even our optimistic bull case (7,566 KRW). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (3,688 KRW to 7,566 KRW) leaves room in how you read the outcome.

Key figures of Seers Technology

How large is the market capitalisation of Seers Technology (458870)?
The market capitalisation of Seers Technology is 1.1T KRW (≈ $766M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Seers Technology (458870)?
The price-to-sales ratio of Seers Technology is 14.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Seers Technology (458870)?
The net margin of Seers Technology is 33.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Seers Technology (458870)?
The return on equity (ROE) of Seers Technology is 80.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Seers Technology (458870)?
On an EBIT basis the return on assets of Seers Technology is −22.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Seers Technology (458870)?
The operating margin of Seers Technology is 42.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Seers Technology (458870)?
Revenue at Seers Technology is growing +700% versus a year earlier (3y avg +247%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Seers Technology (458870)?
Earnings per share at Seers Technology are growing +29.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Seers Technology (458870) generate?
The free cash flow of Seers Technology is 454M KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Seers Technology (458870) carry?
The net debt of Seers Technology is 438M KRW (fiscal year 2023, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Seers Technology in the live analysis

One click puts Seers Technology on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.